As degradation is mediated through CRL4CRBN, and because CRBN expression levels are high in the central nervous system (CNS), we assessed the effects of IMiDs in two different neuroblastoma cell lines, Kelly and SK-N-DZ cells, as well as the commonly used multiple myeloma cell line, MM1s, as a control. This evidence concerns the gene CRBN and AL amyloidosis.